Providing "scientific advice" to pharma industry undermines the independence of regulatory authorities
Attachment: 20140715scientificadvice.pdf
'Investor-to-state dispute settlement' in EU-US trade deal threatens access to affordable medicines
Attachment: 20140711_isdsinttip.pdf
EMA's new policy on access to clinical data: About to privatise pharmaceutical knowledge? The proof will be in the pudding
Attachment: 20140624_emanewpolicyaccessclinicaldata.pdf
Backpedalling on EMA's "proactive publication of clinical-data" draft policy: Was it all just a window-dressing exercise? Who or what is the EMA afraid of?
Attachment: 20140520_ematransparencypolicy.pdf
The November 2014 issue of the ISDB Newsletter (vol 29, issue 2) includes:
-
preliminary announcement of the ISDB General Assembly, scheduled to take place in Pamplona, Spain in June 2015
-
draft program for the 2015 ISDB General Assembly
Read more...